{"hands_on_practices": [{"introduction": "At the heart of biological function are the interactions between molecules. To formally capture these dynamics, SBOL uses the `Interaction` class, where each participant's function is precisely defined by a role from the Systems Biology Ontology (SBO). This first exercise challenges you to model a simple but common synthetic biology motif—protease-mediated degradation—by correctly assigning the roles of 'catalyst' and 'degraded' to the participating proteins [@problem_id:2066840]. Mastering this skill is the first step toward describing complex system behavior.", "problem": "In the field of synthetic biology, the Synthetic Biology Open Language (SBOL) is a standard used to represent the structure and function of genetic designs. A key element of SBOL is the `Interaction` class, which describes how different biological components influence one another. Each participant in an `Interaction` is assigned a role defined by a term from the Systems Biology Ontology (SBO).\n\nConsider a simple synthetic circuit where a protease, `TEVp_protein`, is designed to recognize and cleave a specific target protein, `GFP_MBD_protein`. The target protein is a fusion of a Green Fluorescent Protein (GFP) and a Maltose-Binding Domain, linked by a sequence that the protease can cut. This cleavage event leads to the subsequent degradation of the `GFP_MBD_protein`. Both `TEVp_protein` and `GFP_MBD_protein` are represented as `Component` instances.\n\nYou are tasked with creating an `Interaction` named `TEVp_cleaves_GFP_MBD` to model this degradation process. The `type` of this interaction is correctly set to `SBO:0000179`, which corresponds to \"degradation\".\n\nWhich of the following sets of `Participation` elements correctly defines the roles of the `TEVp_protein` and `GFP_MBD_protein` in this interaction?\n\nA.\n- Participation 1: `participant` = `TEVp_protein`, `role` = `SBO:0000019` (catalyst)\n- Participation 2: `participant` = `GFP_MBD_protein`, `role` = `SBO:0000642` (degraded)\n\nB.\n- Participation 1: `participant` = `GFP_MBD_protein`, `role` = `SBO:0000019` (catalyst)\n- Participation 2: `participant` = `TEVp_protein`, `role` = `SBO:0000642` (degraded)\n\nC.\n- Participation 1: `participant` = `TEVp_protein`, `role` = `SBO:0000011` (product)\n- Participation 2: `participant` = `GFP_MBD_protein`, `role` = `SBO:0000010` (reactant)\n\nD.\n- Participation 1: `participant` = `TEVp_protein`, `role` = `SBO:0000250` (promoter)\n- Participation 2: `participant` = `GFP_MBD_protein`, `role` = `SBO:0000316` (terminator)\n\nE.\n- Participation 1: `participant` = `TEVp_protein`, `role` = `SBO:0000020` (inhibitor)\n- Participation 2: `participant` = `GFP_MBD_protein`, `role` = `SBO:0000643` (inhibited)", "solution": "We are modeling a degradation interaction in SBOL with type set to SBO:0000179, which denotes a degradation process. In such an interaction:\n- The molecule that undergoes degradation is assigned the role “degraded,” which corresponds to SBO:0000642.\n- Any enzyme that facilitates or speeds up the degradation without being consumed is assigned the role “catalyst,” which corresponds to SBO:0000019.\n\nIn the described system, `TEVp_protein` is a protease that recognizes and cleaves the target fusion protein `GFP_MBD_protein`, thereby initiating its degradation. Therefore:\n- `TEVp_protein` serves as the catalyst and should have role SBO:0000019.\n- `GFP_MBD_protein` is the species being degraded and should have role SBO:0000642.\n\nNow evaluate the provided options:\n- Option A assigns `TEVp_protein` as catalyst (SBO:0000019) and `GFP_MBD_protein` as degraded (SBO:0000642). This matches the correct roles for a degradation interaction.\n- Option B incorrectly swaps the roles, assigning the target as catalyst and the protease as degraded, which contradicts the biological function.\n- Option C uses “reactant” (SBO:0000010) and “product” (SBO:0000011), which are generic transformation roles and incorrectly assigns `TEVp_protein` as product; TEVp is not produced in this interaction and acts catalytically.\n- Option D uses “promoter” (SBO:0000250) and “terminator” (SBO:0000316), which are DNA-level sequence feature roles, irrelevant to a protein degradation interaction.\n- Option E uses “inhibitor” (SBO:0000020) and “inhibited” (SBO:0000643), which describe inhibition interactions, not degradation.\n\nTherefore, the only correct set of Participation elements is in option A.", "answer": "$$\\boxed{A}$$", "id": "2066840"}, {"introduction": "Biological designs rarely consist of a single step; they are typically pathways or networks of connected processes. This practice moves from a single interaction to modeling a simple two-step metabolic pathway. Your task is to determine the minimal set of SBOL objects required to represent this system without ambiguity [@problem_id:2066823]. This exercise will sharpen your ability to translate a biological schematic into a structured and complete data model, a crucial skill for systematic design.", "problem": "A synthetic biologist is designing a simple biosynthetic pathway and wants to create a formal representation of it using the Synthetic Biology Open Language (SBOL). The pathway consists of two sequential enzymatic reactions. In the first step, a substrate molecule, `S`, is converted into an intermediate molecule, `I`, catalyzed by an enzyme, `E1`. In the second step, the intermediate molecule, `I`, is converted into the final product molecule, `P`, catalyzed by a second, different enzyme, `E2`.\n\nTo model this system in SBOL, one must define the components and the interactions between them. The core SBOL data model objects for this task are `Component` (to represent the physical entities), `Interaction` (to represent the processes), and `Participation` (to link entities to processes with specific roles).\n\nAssuming the most parsimonious representation that captures all specified entities and processes without ambiguity, what is the minimum number of `Component`, `Interaction`, and `Participation` objects required to model this two-step metabolic pathway?\n\nA. 5 `Component`s, 2 `Interaction`s, 6 `Participation`s\n\nB. 3 `Component`s, 2 `Interaction`s, 4 `Participation`s\n\nC. 5 `Component`s, 1 `Interaction`, 4 `Participation`s\n\nD. 5 `Component`s, 2 `Interaction`s, 4 `Participation`s", "solution": "We model the pathway using SBOL core concepts with the following minimal assumptions:\n- Each distinct physical entity (molecule or enzyme) requires a separate `Component`.\n- Each distinct process (reaction step) requires a separate `Interaction`.\n- Each entity involved in a given `Interaction` must be linked via a `Participation` with an appropriate role, and a `Participation` is scoped to a single `Interaction` (i.e., it cannot be shared across `Interaction`s).\n\nFirst, count `Component`s. The distinct physical entities are the substrate $S$, intermediate $I$, product $P$, and the two enzymes $E1$ and $E2$. Therefore,\n$$\n\\text{Components} = 5 \\quad \\text{for } \\{S, I, P, E1, E2\\}.\n$$\n\nSecond, count `Interaction`s. There are two sequential enzymatic reactions: $S \\rightarrow I$ catalyzed by $E1$, and $I \\rightarrow P$ catalyzed by $E2$. To unambiguously represent two distinct processes with different catalysts, we require\n$$\n\\text{Interactions} = 2.\n$$\n\nThird, count `Participation`s. For each enzymatic reaction, the minimal roles are substrate (reactant), product, and catalyst. Thus, for each `Interaction` there are exactly $3$ `Participation`s:\n- For $S \\rightarrow I$ catalyzed by $E1$: $S$ as reactant, $I$ as product, $E1$ as catalyst.\n- For $I \\rightarrow P$ catalyzed by $E2$: $I$ as reactant, $P$ as product, $E2$ as catalyst.\n\nSince `Participation`s are per `Interaction`, the intermediate $I$ requires one `Participation` in each `Interaction`. Therefore, the total number of `Participation`s is\n$$\n\\text{Participations} = 3 \\times 2 = 6.\n$$\n\nCombining these, the minimal unambiguous representation uses $5$ `Component`s, $2$ `Interaction`s, and $6$ `Participation`s, which corresponds to option A.", "answer": "$$\\boxed{A}$$", "id": "2066823"}, {"introduction": "A key advantage of formal design languages like SBOL is their ability to prevent errors before they happen in the lab. This practice connects the abstract SBOL data model to the concrete physical constraints of DNA assembly. You will act as a design validator, analyzing an SBOL representation of a Golden Gate assembly to find a subtle but critical error in the specified overhangs [@problem_id:2066806]. This demonstrates how SBOL's `Constraint` feature can be used to ensure a design is physically buildable.", "problem": "A synthetic biologist is designing a bacterial expression cassette using the Golden Gate assembly method with the Type IIs restriction enzyme BsaI. The design, which specifies the linear ordering of genetic parts, is formally described using the Synthetic Biology Open Language (SBOL). The design consists of four basic parts: a promoter, a Ribosome Binding Site (RBS), a Coding Sequence (CDS), and a terminator.\n\nThe Golden Gate assembly protocol for this project requires that for any two parts to be ligated together, the 4-base-pair (bp) overhang at the 3' end of the preceding part must be identical to the 4-bp overhang at the 5' end of the succeeding part.\n\nThe SBOL document contains `Component` objects for each genetic part and `Constraint` objects to define their relative order. Below is a summary of the relevant data from the SBOL document.\n\n**Component Definitions:**\nEach part is defined by a `Component` with a unique Uniform Resource Identifier (URI) and specified 5' and 3' overhang sequences.\n\n| URI Fragment | Part Role | 5' Overhang | 3' Overhang |\n| :--- | :--- | :--- | :--- |\n| `p_J23100` | Promoter | `GGAG` | `AATG` |\n| `rbs_B0034`| RBS | `AATG` | `TTCG` |\n| `cds_sfGFP`| CDS | `TTCG` | `GCTC` |\n| `t_L3S2P21`| Terminator | `GCTA` | `CGCT` |\n\n**Sequence Constraints:**\nThe assembly order is specified by `Constraint` objects. Each `Constraint` has a URI and defines a `subject` (preceding part) that must come before an `object` (succeeding part).\n\n| Constraint URI | Subject URI Fragment | Object URI Fragment |\n| :--- | :--- | :--- |\n| `http://example.org/sc/1` | `p_J23100` | `rbs_B0034` |\n| `http://example.org/sc/2` | `rbs_B0034` | `cds_sfGFP` |\n| `http://example.org/sc/3` | `cds_sfGFP` | `t_L3S2P21` |\n\nAn error was made during the design process, resulting in one of the `Constraint`s representing a biochemically invalid ligation junction according to the Golden Gate assembly rules. Identify the URI of the invalid `Constraint`.\n\nA. `http://example.org/sc/1`\n\nB. `http://example.org/sc/2`\n\nC. `http://example.org/sc/3`\n\nD. All constraints represent valid junctions.", "solution": "Golden Gate assembly with a Type IIs enzyme requires that, for two parts to ligate, the 4-bp overhang at the 3' end of the preceding part is identical to the 4-bp overhang at the 5' end of the succeeding part.\n\nCheck each `Constraint` against the overhangs:\n\n1) The `Constraint` with URI http://example.org/sc/1: subject p_J23100 precedes object rbs_B0034. The 3' overhang of p_J23100 is AATG, and the 5' overhang of rbs_B0034 is AATG. These are identical, so this junction is valid.\n\n2) The `Constraint` with URI http://example.org/sc/2: subject rbs_B0034 precedes object cds_sfGFP. The 3' overhang of rbs_B0034 is TTCG, and the 5' overhang of cds_sfGFP is TTCG. These are identical, so this junction is valid.\n\n3) The `Constraint` with URI http://example.org/sc/3: subject cds_sfGFP precedes object t_L3S2P21. The 3' overhang of cds_sfGFP is GCTC, while the 5' overhang of t_L3S2P21 is GCTA. These differ (C versus A at the fourth position), so this junction is invalid.\n\nTherefore, the invalid `Constraint` is http://example.org/sc/3.", "answer": "$$\\boxed{C}$$", "id": "2066806"}]}